GB201110767D0 - Infection imaging - Google Patents

Infection imaging

Info

Publication number
GB201110767D0
GB201110767D0 GBGB1110767.9A GB201110767A GB201110767D0 GB 201110767 D0 GB201110767 D0 GB 201110767D0 GB 201110767 A GB201110767 A GB 201110767A GB 201110767 D0 GB201110767 D0 GB 201110767D0
Authority
GB
United Kingdom
Prior art keywords
vivo imaging
imaging agent
preparation
present
precursor compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1110767.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Priority to GBGB1110767.9A priority Critical patent/GB201110767D0/en
Publication of GB201110767D0 publication Critical patent/GB201110767D0/en
Priority to PCT/EP2012/062130 priority patent/WO2012175702A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Abstract

The present invention provides radiolabelled RIF derivatives that are suitable for in vivo imaging of bacterial infection. The in vivo imaging agent of the invention is preferably provided as a radiopharmaceutical composition, which forms a further aspect of the invention. Also provided by the present invention is a precursor compound useful in the preparation of the in vivo imaging agent of the invention, a method for the preparation of the in vivo imaging agent of the invention comprising reaction of the precursor compound with a suitable source of the desired radiolabel, and methods for the use of the in vivo imaging compound.
GBGB1110767.9A 2011-06-24 2011-06-24 Infection imaging Ceased GB201110767D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1110767.9A GB201110767D0 (en) 2011-06-24 2011-06-24 Infection imaging
PCT/EP2012/062130 WO2012175702A1 (en) 2011-06-24 2012-06-22 Rimfampicin analogue useful for infection imaging

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1110767.9A GB201110767D0 (en) 2011-06-24 2011-06-24 Infection imaging

Publications (1)

Publication Number Publication Date
GB201110767D0 true GB201110767D0 (en) 2011-08-10

Family

ID=44485132

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1110767.9A Ceased GB201110767D0 (en) 2011-06-24 2011-06-24 Infection imaging

Country Status (2)

Country Link
GB (1) GB201110767D0 (en)
WO (1) WO2012175702A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3294291B1 (en) 2015-05-10 2021-01-13 The Trustees Of The University Of Pennsylvania Radiotracer derivatives of trimethoprim for diagnostic imaging

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0116815D0 (en) 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
GB0416062D0 (en) 2004-07-19 2004-08-18 Amersham Plc Improved N4 chelator conjugates

Also Published As

Publication number Publication date
WO2012175702A1 (en) 2012-12-27

Similar Documents

Publication Publication Date Title
IL257330B (en) Compositions, methods and kits for diagnosis of lung cancer
MX339878B (en) Novel solid forms of bendamustine hydrochloride.
TW201231056A (en) Metal salt compositions
IL222897A (en) Compositions, compounds and methods for the synthesis and use of imaging agents
EP2669289A4 (en) Phosphorus substituted group-containing quinoline-like compound, its preparation process, medical composition containing the compound and application
PH12014501108A1 (en) Anti-il-36r antibodies
MY150542A (en) Cmet inhibitors
GEP201706745B (en) Forms of rifaximin and usage thereof
EP2609220A4 (en) Association of rare recurrent genetic variations to attention-deficit, hyperactivity disorder (adhd) and methods of use thereof for the diagnosis and treatment of the same
EP2582664A4 (en) Phenylthioacetate compounds, compositions and methods of use
WO2012149412A3 (en) Anti-endoglin (cd105) antibodies, immunoconjugates, and uses thereof
MX2019012939A (en) Linaclotide-containing formulations for oral administration.
TN2009000063A1 (en) Compounds and methods for 18f labeled agents
EP2586768A4 (en) Hydroxy acid compound of substituted phenyl ester, preparation method and medical use thereof
MX2013012793A (en) Radiolabeled amino acids for diagnostic imaging.
BR112013013285A2 (en) imaging agent, precursor, imaging, and imaging methods, radiopharmaceutical composition, kit for preparing the radiopharmaceutical composition, and use of the imaging agent
IN2012DN03404A (en)
EP2257316A4 (en) Contrast agents, methods for preparing contrast agents, and methods of imaging
MX336369B (en) Use of ellagic acid as an anti-dandruff agent.
AU2010332841A8 (en) Prostate specific membrane antigen inhibitors
EP2119766A4 (en) Agent for improving viability of lactic acid bacterium
WO2011146390A3 (en) Compositions and methods for in vivo imaging
MX2013009386A (en) New azaspirodecanone compounds.
MX2013003859A (en) Picropodophyllin polymorphs b or c for use in cancer therapy.
IL212850A0 (en) Novel method for the preparation of granulates of active constituents, and granulates as obtained

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)